Innovation Fuels New Cannabis Based Skin Care Medicines - NEWC's Pharmaceutical Partner in Discussions with City of Medellin

CORAL SPRINGS, Florida, May 20, 2014 /PRNewswire/ --

Medical Marijuana industry expansion continues as medical developments give way to new opportunities including Cannabis Based Skin Care Medicines: New Colombia Resources, Inc. (OTC: NEWC), Cannabis Science, Inc. (OTC: CBIS), Hemp, Inc. (OTC: HEMP), Nuvilex, Inc. (OTC: NVLX), and Tranzbyte Corporation (OTC: ERBB)

New Colombia Resources, Inc. (OTCQB: NEWC), a U.S. company with coal and other resource assets in Colombia, is pleased to announce they are in discussions with their pharmaceutical partner in Colombia to enter to an innovation program offered by the City of Medellín.  The Ruta N organization was created to promote the development of innovative science and technology-based businesses in the city of Medellin, the winner in 2013 of the world's "Innovative City of Year" award by the Wall Street Journal and Citi.

New Colombia Resources' Medellin based pharmaceutical partner, Farmatech S.A., is meeting with Ruta N to establish the protocols needed to enter the program. Ruta N has created various projects and programs that articulate research and high-impact entrepreneurship by supporting innovative initiatives that have great potential in the global market.  For more information on the Ruta N program visit http://rutanmedellin.org/index.php/en

To read the full press release, please click here:http://www.fnmprofiles.com/profiles-newc.html

New Colombia is in discussions with Cannabis Science Inc. (OTCQB: CBIS) to oversee this program along with their scientific advisor Dr. Robert Melamede, President of Cannabis Science Inc. (CBIS). "This program will benefit our efforts for approvals for research and development of legal cannabis based pharmaceutical products in Colombia," stated John Campo, President of New Colombia Resource, Inc.

Hemp, Inc. (OTC Pink: HEMP) announced today that it has purchased a whole line of automated Temafa decortication equipment designed to separate the fiber from the core of the hemp plant through a process known as decortication. The Temafa decortication line of equipment, the only one of its kind in the United States, purchased by Hemp, Inc. will now enable the company to process raw hemp for American farmers into two valuable base products (fiber and hurd) that can both yield hundreds of products. The equipment is currently located at a plant in North Carolina. Hemp, Inc. is set to move the equipment to a more suitable location such as Kentucky, Tennessee, South Carolina, North Carolina, or the Georgia area. "This purchase of decortication equipment was a critical step in order for Hemp, Inc. to help Americans transition from non-sustainable synthetic solutions to a hemp-based green solution. We are very excited at what we'll be able to achieve once our manufacturing facility ramps its hemp production volume up over the next few years," said Perlowin, CEO of Hemp, Inc.

Nuvilex, Inc. (OTCQB: NVLX) recently announced that it signed an agreement with the University of Northern Colorado to perform initial studies in the development of cancer treatments that combine the proprietary live-cell encapsulation technology Cell-in-a-Box^® with constituents of cannabis known as cannabinoids. It was another quiet announcement that seemed to fly under the radar, and maybe purposely so, as Nuvilex is a biotechnology firm that wants to stay just that, but at the same time, the company wants to use all available tools to potentially improve its own cancer treatments and, in turn, potentially save lives. And that means medical marijuana needs to be an option given it has proven it has medicinal properties. So, in what has been Nuvilex's modus operandi over the last year or so, the company has sought out cannabis industry professionals in an attempt to position itself as a leader in medical marijuana. Unlike many companies that reside permanently in the cannabis space, putting out news daily with no substance and seemingly no end in sight to the claims, Nuvilex has methodically put together a world class Scientific Advisory Board (SAB) at its wholly owned subsidiary Medical Marijuana Sciences.

Tranzbyte Corporation (OTC Pink: ERBB) attracts established and early growth businesses seeking to take advantage of resources through the public capital markets and provides them capital, legal, accounting, and public relations resources. Tranzbyte recently announced that it will change its corporate name to AMERICAN GREEN™. The name change should be effective sometime within the next several weeks and is subject to review by FINRA and The State of Nevada. ERBB closed down on Monday (5/19/2014) at $0.021 on Heavy Volume Trading over 89 Million shares by the market close.

FinancialNewsMedia.com  is leading provider of third party publishing &  news dissemination services. If you would like more information regarding our news coverage solutions, please visit  http://www.financialnewsmedia.com for more details.  Get an edge on the market with our  Premium News Alerts  that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook:  http://www.facebook.com/financialnewsmedia and Twitter: http://twitter.com/FNMgroup. 

DISCLAIMER:  FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNMG is NOT affiliated in any manner with any company mentioned herein.  FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNMG is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNMG was not compensated for this New Colombia Resources, Inc. news coverage but expects to be compensated in the future which will be fully disclosed at that time.  FNMG HOLDS NO SHARES OF New Colombia Resources, Inc.

FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.  

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company:  FN Media Group, LLC
Contact email:  [email protected]
U.S. Phone: +1(954)345-0611 
URL: http://www.financialnewsmedia.com

SOURCE FN Media Group, LLC